跳至主要内容
临床试验/NCT02399072
NCT02399072终止不适用

A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration

Hoffmann-La Roche63 个研究点 分布在 10 个国家目标入组 202 人开始时间: 2015年3月30日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
202
试验地点
63
主要终点
Mean Change from Baseline in the GA Area as Assessed by Fundus Autofluorescence (FAF) up to Month 60

研究概览

简要总结

This study seeks to better characterize relationships between visual function and the progression (worsening) of geographic atrophy (GA) due to age-related macular degeneration (AMD). The study also will generate new information on the relationship between genetics and GA progression. This is a global, prospective, multicenter, epidemiologic study enrolling 200 participants with GA secondary to AMD. The study visits are scheduled to occur every 6 months. The anticipated duration of the study is up to 60 months.

研究设计

研究类型
Observational

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Well-demarcated area of GA secondary to AMD
  • Women of childbearing potential and men must agree to use adequate contraception for at least 30 days after fluorescein dye administration
  • The study is recruiting participants in two different cohorts:
  • Cohort 1: Participants with unilateral GA OR Cohort 2: Participants with GA in one eye and CNV (active or treated) with or without GA, in the contralateral eye

排除标准

  • Previous participation in any studies of investigational drugs for GA / dry AMD (exception for studies of vitamins and minerals)
  • GA in either eye due to causes other than AMD
  • History of vitrectomy surgery, submacular surgery, or any surgical intervention for AMD
  • Previous laser photocoagulation for CNV, diabetic macular edema, retinal vein occlusion, and/or proliferative diabetic retinopathy
  • Any ocular/systemic medical conditions that, in the opinion of the investigator, could contribute to participant's inability to participate in the study or interfere with study assessments.
  • Requirement for continuous use of therapy indicated in Prohibited Therapy

结局指标

主要结局

Mean Change from Baseline in the GA Area as Assessed by Fundus Autofluorescence (FAF) up to Month 60

时间窗: Baseline up to Month 60

次要结局

  • Change from Baseline in Binocular Reading Speed as Assessed by Minnesota Low-Vision Reading Test (MNRead) Cards or Radner Reading Cards up to Month 60(Baseline up to Month 60)
  • Change from Baseline in Monocular Reading Speed as Assessed by MNRead Cards or Radner Reading Cards up to Month 60(Baseline up to Month 60)
  • Percentage of Participants With Medical Events(Baseline up to Month 60)
  • Percentage of Participants With Ocular Events(Baseline up to Month 60)
  • Change from Baseline in Best Corrected Visual Acuity (BCVA) Score as Assessed by Early Treatment Diabetic Retinopathy Study (ETDRS) Chart up to Month 60(Baseline up to Month 60)
  • Change from Baseline in BCVA Score as Assessed by ETDRS Chart Under Low Luminance Conditions up to Month 60(Baseline up to Month 60)
  • Change from Baseline in Binocular Critical Print Size as Assessed by MNRead Cards or Radner Reading Cards up to Month 60(Baseline up to Month 60)
  • Change from Baseline in Monocular Critical Print Size as Assessed by MNRead Cards or Radner Reading Cards up to Month 60(Baseline up to Month 60)
  • Change from Baseline in Near Activity Subscale as Assessed by National Eye Institute Visual Functioning Questionnaire 25-Item Version (NEI VFQ-25) up to Month 60(Baseline up to Month 60)
  • Change from Baseline in Distance Activity Subscale as Assessed by NEI VFQ-25 up to Month 60(Baseline up to Month 60)
  • Change from Baseline in Composite Scores as Assessed by NEI VFQ-25 up to Month 60(Baseline up to Month 60)
  • Change from Baseline in Functional Reading Independence Score up to Month 60(Baseline up to Month 60)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (63)

Loading locations...

相似试验